Pure Global
NCT05486455

Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers

Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers: a Real Life Study
Hospital St. Joseph, Marseille, France·ClinicalTrials.gov·diagnostic testNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking
Drug/Device/Intervention
Low-dose chest CT scan
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Hospital St. Joseph, Marseille, France
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2022
End date
Oct 01, 2028
Enrollment
1000 participants
Primary outcome

Positive Predictive Value (PPV)

Summary

Diagnostic performance of low-dose chest CT scan combined with lung-RADS classification
 (version 1.1) for lung cancer screening among former and current smokers.

ICD-10 classifications
Tobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco : harmful useDrug use
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05486455
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05486455 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospital St. Joseph, Marseille, France and is currently Not yet recruiting. The study focuses on Smoking. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.